{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Non-relapse mortality refers to whether a patient dies of causes related to something other than the primary disease.","groups":[{"description":"Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"NUMBER","populationDescription":"6 patients died prior to one year and therefore are eligible to be evaluated for non-relapse mortality.","reportingStatus":"POSTED","timeFrame":"1 year","title":"Non-relapse Mortality at 1 Year After Peripheral Blood Stem Cell Transplantation (PBSCT)","type":"SECONDARY","unitOfMeasure":"participants"}